Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Empower Clinics Inc EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.


GREY:EPWCF - Post by User

Post by Smokey1958on Mar 01, 2023 3:18pm
445 Views
Post# 35313290

Good News, Bad News

Good News, Bad News

The NR today provides some positive news, some potential and some bad news that may finally be behind us.

The good news is that revenues seem to be tied to Medisure ....this was definitely a positive acquisition. In fact Medisure continues to be meeting expectations and with some approvals for their products in the US should be able to forecast significant growth.

The potential is in Medisure acquiring these approvals sooner rather than later. While not a part of current revenues hopefully the expectation of Medisure Labs being a testing site for new diagnostic products will also come to fruition in the second half of this year.

That revenues from the Medi Collective are down is not surprising. That this chapter may finally be closed at least puts this in the rear view mirror. Unfortunately, as it turns out, a lot of capital both literally and as goodwill to investors has been wasted. Steve still has much to do to restore investor confidence. It is hard to imagine this can be done now without an RTO ....and we know how these usually work out.

The annual financials for 2022 will probably look better than this quarterly only because it is quite clear that covid testing had become a significant driver of revenue. With some "luck" these will come out on time ...likely by the end of June (with the new year end) and will be the final chapter on the previous direction. While it no doubt should and has left a bitter taste it can be hoped that by this time the $.05 PP has demonstrated some merit.

GLTE!!!

<< Previous
Bullboard Posts
Next >>